Johnson Matthey buys Sweden's Formox
Speciality chemicals group Johnson Matthey said it has completed the purchase of formaldehyde producer Formox for 107m pounds in cash from Perstorp Specialty Chemicals, a company owned by PAI Partners.
Speciality chemicals group Johnson Matthey said it has completed the purchase of formaldehyde producer Formox for 107m pounds in cash from Perstorp Specialty Chemicals, a company owned by PAI Partners.
Formox provides catalysts, plant designs and licences for the manufacture of chemical intermediate formaldehyde, Johnson Matthey explained in a statement.
"The acquisition enhances our position as a leading supplier of technology for a range of syngas and other chemical processes. The addition of Formox's formaldehyde technology provides exciting opportunities to integrate and expand our technology and catalysts into a broader range of chemical processes," Johnson Matthey said.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Furthermore, the Swedish firm's expertise in selective oxidation catalysis, a technology that has application in a number of other catalyst areas, is also expected to provide more opportunities for Johnson Matthey to grow its position in the global petrochemicals market.
Commenting on the deal, Johnson Matthey Chief Executive Neil Carson said: "The acquisition of Formox complements our existing technologies for process catalysts, plant design and licensing."
"Formox has a strong position in a growing and profitable market which gives Johnson Matthey new opportunities to grow its sales of catalysts and process technology into the wider petrochemicals market."
CJ
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Investing in pharmaceutical companies? The pipeline is key
A strong pipeline is all-important for pharmaceutical companies. We highlight the most interesting candidates.
By Dr Mike Tubbs Published
-
RICS: Property sales rise as interest rates fall and stamp duty hike looms
Estate agents are feeling bullish about the market, with house prices forecast to rise over the next three months. But difficulties continue to mount for renters
By Ruth Emery Published